Form 4 · Filed Jun 3, 2026, 09:04 PM UTC
MAZE/Maze Therapeutics, Inc.
Coloma Jason V — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | S | sell | 6,090 | $26 | $159,537 | 344,897 |
| Jun 1, 2026 | S | sell | 553 | $26 | $14,511 | 27,970 |
Source: SEC EDGAR raw filing ↗ · Accession 0001676170-26-000009